These included regulators of the RAS MAPK pathway, including SPRED1-encoding Spred-1 and MAP2K5, both of which are known to reduce tumor growth, although the latter promotes invasiveness in breast cancer [34,35] (Figure 2C). Here, SPRED1 is linked to breast carcinoma.